Niki BioSolutions, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Niki BioSolutions, Inc. (NIKI) had Deferred Tax Assets, Operating Loss Carryforwards of $15.37 million as of 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-05-11
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $15.37M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $15.11M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $16.96M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $14.87M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $15.37M S-4/A · filed 2026-05-11 |
| 2024-12-31 | $15.11M S-4/A · filed 2026-05-11 |
| 2023-12-31 | $16.96M 6-K · filed 2025-10-08 |
| 2022-12-31 | $14.87M 20-F · filed 2024-04-30 |
| 2021-12-31 | $12.19M 20-F · filed 2023-04-28 |
| 2020-12-31 | $9.46M 20-F/A · filed 2023-01-17 |
| 2019-12-31 | $6.70M 20-F · filed 2021-04-19 |
| 2018-12-31 | $3.50M 20-F · filed 2020-04-29 |
| 2017-12-31 | $1.25M 20-F · filed 2019-04-15 |